^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BAT8003

    i
    Other names: BAT8003, BAT 8003, Anti-Trop-2 ADC
    Company:
    Bio-Thera Solutions
    Drug class:
    Microtubule inhibitor, TROP-2-targeted antibody-drug conjugate
    Related drugs:
    1year
    Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer (clinicaltrials.gov)
    P1, N=5, Terminated, Bio-Thera Solutions | N=50 --> 5 | Unknown status --> Terminated; Considering that the safety risk will affect the subsequent development, it is decided to terminate the test voluntarily
    Enrollment change • Trial termination • Metastases
    |
    TACSTD2 (Tumor Associated Calcium Signal Transducer 2)
    |
    TROP2 expression • TROP2 positive
    |
    BAT8003